Found: 6
Select item for more details and to access through your institution.
Drug‐induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann–Pick type C cells and mice.
- Published in:
- EMBO Reports, 2019, v. 20, n. 7, p. N.PAG, doi. 10.15252/embr.201847055
- By:
- Publication type:
- Article
Defective platelet function in Niemann‐Pick disease type C1.
- Published in:
- Journal of Inherited Metabolic Disease Reports, 2020, v. 56, n. 1, p. 46, doi. 10.1002/jmd2.12148
- By:
- Publication type:
- Article
FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
- Published in:
- FASEB Journal, 2017, v. 31, n. 4, p. 1719, doi. 10.1096/fj.201601041R
- By:
- Publication type:
- Article
Immune dysfunction in Niemann-Pick disease type C.
- Published in:
- Journal of Neurochemistry, 2016, v. 136, p. 74, doi. 10.1111/jnc.13138
- By:
- Publication type:
- Article
Mechanistic convergence and shared therapeutic targets in Niemann‐Pick disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2020, v. 43, n. 3, p. 574, doi. 10.1002/jimd.12191
- By:
- Publication type:
- Article
AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann–Pick type C1 disease.
- Published in:
- Human Molecular Genetics, 2018, v. 27, n. 17, p. 3079, doi. 10.1093/hmg/ddy212
- By:
- Publication type:
- Article